anti-CD18 monoclonal antibody (Corange/PDL)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD18 monoclonal antibody (Corange/PDL)
Drug Alias Nameanti-CD18 MAb (Corange/PDL)SMART anti-CD18SMART anti-CD18 MAb (Protein Design Labs)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionIntegrin beta-2 inhibitors
TargetsIntegrin beta-2
Therapy Area/IndicationsInflammationRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorld
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPdl Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Mannheim GmbhPdl Biopharma Inc
Active IndicationsN/A
Inactive IndicationsInflammationRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A